KinBio

Pharmaceuticals

Health Tech & Life Sciences
Non Active, Jan 2025 ceased to operate
Pre-Funding Hong Kong Founded 2018
LinkedIn
Total raised
Stage
Pre-Funding
Founded
2018
Headcount
18
HQ
Hong Kong
Sector
Health Tech & Life Sciences

About

KinBio is wholly-owned local subsidiary of Hong Kong-based pharmaceutical and food retailer Gencor Pacific which had acquired the assets of Israel-based pharmaceutical company InSight. KinBio is developing a large portfolio of technologies for manufacturing generic versions of complex drugs, high-quality biosimilars and biologics. The company is specialized in the research, development, manufacturing and global commercialization of biosimilars to treat and prevent diseases across several different therapeutic areas including CNS, inflammation, oncology, and osteoporosis. .

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical Biotechnology
Business model
B2B

Tags

pharmaceuticalsoncology